Mutation in Plasmodium chabaudi Linked to Drug Resistance
Author Information
Author(s): Martinelli Axel, Henriques Gisela, Cravo Pedro, Hunt Paul
Primary Institution: Centro de Malaria e Outras Doenças Tropicais/IHMT/UEI Biologia Molecular, Universidade Nova de Lisboa
Hypothesis
Does a mutation in the mdr2 gene affect the susceptibility of Plasmodium chabaudi to antifolate drugs?
Conclusion
The study identifies a mutation in the mdr2 gene that is linked to increased resistance to sulphadoxine in Plasmodium chabaudi.
Supporting Evidence
- A mutation in the mdr2 gene was found to be linked to drug resistance.
- Four point mutations were identified in the genome of the resistant clone.
- Previous studies indicated that genetic markers on chromosome 13 are associated with drug responses.
Takeaway
Scientists found a change in a gene that helps a malaria parasite resist a type of medicine. This could help us understand how to fight malaria better.
Methodology
The researchers sequenced the genome of a drug-resistant malaria clone and compared it to a sensitive progenitor to identify mutations.
Limitations
The study primarily focuses on a single clone, which may not represent broader genetic variations in malaria.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website